91 related articles for article (PubMed ID: 20564142)
1. Clonal origin of multifocal hepatocellular carcinoma.
Hodges KB; Cummings OW; Saxena R; Wang M; Zhang S; Lopez-Beltran A; Montironi R; Nour H; Cheng L
Cancer; 2010 Sep; 116(17):4078-85. PubMed ID: 20564142
[TBL] [Abstract][Full Text] [Related]
2. Evidence for common clonal origin of multifocal lung cancers.
Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
[TBL] [Abstract][Full Text] [Related]
3. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
5. Molecular evidence supporting field effect in urothelial carcinogenesis.
Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
[TBL] [Abstract][Full Text] [Related]
6. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
[TBL] [Abstract][Full Text] [Related]
7. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
[TBL] [Abstract][Full Text] [Related]
8. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma.
Cheng L; MacLennan GT; Zhang S; Wang M; Zhou M; Tan PH; Foster S; Lopez-Beltran A; Montironi R
Clin Cancer Res; 2008 Dec; 14(24):8087-93. PubMed ID: 19088024
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors.
Emerson RE; Wang M; Roth LM; Zheng W; Abdul-Karim FW; Liu F; Ulbright TM; Eble JN; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):368-74. PubMed ID: 17885485
[TBL] [Abstract][Full Text] [Related]
10. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis.
Katona TM; Jones TD; Wang M; Abdul-Karim FW; Cummings OW; Cheng L
Cancer Res; 2006 May; 66(9):4936-42. PubMed ID: 16651451
[TBL] [Abstract][Full Text] [Related]
12. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin.
Tsuda H; Oda T; Sakamoto M; Hirohashi S
Cancer Res; 1992 Mar; 52(6):1504-9. PubMed ID: 1347253
[TBL] [Abstract][Full Text] [Related]
13. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
15. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
[TBL] [Abstract][Full Text] [Related]
16. Clonality and TP53 mutation analysis of focal nodular hyperplasia of the liver.
Zheng S; Cummings OW; Saxena R; Zhang S; Wang M; Williamson SR; Cheng M; Lopez-Beltran A; Montironi R; Hodges KB; Cheng L
Am J Clin Pathol; 2010 Jul; 134(1):65-70. PubMed ID: 20551268
[TBL] [Abstract][Full Text] [Related]
17. Clonal origin of metastatic testicular teratomas.
Jones TD; Wang M; Sung MT; Zhang S; Ulbright TM; Eble JN; Beck SD; Foster RS; Anagnostou JJ; Conner C; Cheng L
Clin Cancer Res; 2006 Sep; 12(18):5377-83. PubMed ID: 16982812
[TBL] [Abstract][Full Text] [Related]
18. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono S; Chou MJ; Lee CS; Shih C
Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
[TBL] [Abstract][Full Text] [Related]
19. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]